KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Medpace Holdings (MEDP) Return on Sales: 2016-2025

Historic Return on Sales for Medpace Holdings (MEDP) over the last 10 years, with Sep 2025 value amounting to 0.18%.

  • Medpace Holdings' Return on Sales rose 1.00% to 0.18% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.18%, marking a year-over-year increase of 1.00%. This contributed to the annual value of 0.19% for FY2024, which is 4.00% up from last year.
  • Per Medpace Holdings' latest filing, its Return on Sales stood at 0.18% for Q3 2025, which was down 2.04% from 0.19% recorded in Q2 2025.
  • In the past 5 years, Medpace Holdings' Return on Sales ranged from a high of 0.19% in Q1 2025 and a low of 0.15% during Q4 2023.
  • For the 3-year period, Medpace Holdings' Return on Sales averaged around 0.17%, with its median value being 0.17% (2024).
  • Its Return on Sales has fluctuated over the past 5 years, first climbed by 5bps in 2021, then fell by 2bps in 2023.
  • Quarterly analysis of 5 years shows Medpace Holdings' Return on Sales stood at 0.16% in 2021, then increased by 1bps to 0.17% in 2022, then fell by 2bps to 0.15% in 2023, then grew by 4bps to 0.19% in 2024, then increased by 1bps to 0.18% in 2025.
  • Its Return on Sales stands at 0.18% for Q3 2025, versus 0.19% for Q2 2025 and 0.19% for Q1 2025.